Pharmacological Modulation of Ubiquitin-Proteasome Pathways in Oncogenic Signaling.
Anmol Sharma,Heena Khan,Thakur Gurjeet Singh,Amarjot Kaur Grewal,Agnieszka Najda,Małgorzata Kawecka-Radomska,Mohamed Kamel,Ahmed E. Altyar,Mohamed M. del-Daim +8 more
Reads0
Chats0
TLDR
A systematic literature review of PubMed, Medline, Bentham, Scopus, and EMBASE (Elsevier) databases was carried out to understand the nature of the extensive work done on modulation of ubiquitin-proteasome pathways in oncogenic signaling as discussed by the authors.Abstract:
The ubiquitin-proteasome pathway (UPP) is involved in regulating several biological functions, including cell cycle control, apoptosis, DNA damage response, and apoptosis. It is widely known for its role in degrading abnormal protein substrates and maintaining physiological body functions via ubiquitinating enzymes (E1, E2, E3) and the proteasome. Therefore, aberrant expression in these enzymes results in an altered biological process, including transduction signaling for cell death and survival, resulting in cancer. In this review, an overview of profuse enzymes involved as a pro-oncogenic or progressive growth factor in tumors with their downstream signaling pathways has been discussed. A systematic literature review of PubMed, Medline, Bentham, Scopus, and EMBASE (Elsevier) databases was carried out to understand the nature of the extensive work done on modulation of ubiquitin-proteasome pathways in oncogenic signaling. Various in vitro, in vivo studies demonstrating the involvement of ubiquitin-proteasome systems in varied types of cancers and the downstream signaling pathways involved are also discussed in the current review. Several inhibitors of E1, E2, E3, deubiquitinase enzymes and proteasome have been applied for treating cancer. Some of these drugs have exhibited successful outcomes in in vivo studies on different cancer types, so clinical trials are going on for these inhibitors. This review mainly focuses on certain ubiquitin-proteasome enzymes involved in developing cancers and certain enzymes that can be targeted to treat cancer.read more
Citations
More filters
Journal ArticleDOI
Expression of FBXW11 in normal and disease‐associated osteogenic cells
Luca Dalle Carbonare,Macarena Gomez Lira,Arianna Minoia,Jessica Bertacco,Silvia Orsi,Angela Lauriola,Veronica Li Vigni,Alberto Gandini,Franco Antoniazzi,Donato Zipeto,Monica Mottes,Lekhana Bhandary,Daniele Guardavaccaro,Maria Teresa Valenti +13 more
TL;DR: In this article , the ubiquitin-proteasome system (UPS) plays an important role in maintaining cellular homeostasis by degrading a multitude of key regulatory proteins.
Journal ArticleDOI
Mechanistic insights on impact of Adenosine monophosphate-activated protein kinase (AMPK) mediated signalling pathways on cerebral ischemic injury
TL;DR: In this article , the interplay of AMPK signaling between metabolic regulation and neuronal death and its role for pathogenesis and therapeutics has been studied and highlighted a significant signaling pathway, i.e., the adenosine monophosphate-activated protein kinase (AMPK) involved in the relationship between the metabolism and ischemia, which could be used as a target for future studies therapeutics, and review some of the clinical progress in this area.
Journal ArticleDOI
Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination
TL;DR: In this article , a novel coronavirus disease (COVID-19), caused by a severe acute respiratory syndrome (SARS-CoV-2) was discovered in Wuhan, China, in December 2019, and the world has suffered from a pandemic.
Journal ArticleDOI
Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase to Expand the Toolbox for PROTAC Design
Tommaso Palomba,G. Tassone,Carmine Vacca,Matteo Bartalucci,Aurora Valeri,Cecilia Pozzi,Simon S. Cross,Lydia Siragusa,Jenny Desantis +8 more
TL;DR: In this paper , a case study of the cross-relationship using GRID molecular interaction field (MIF) similarities between TRIM24 and TRIM33 binding sites was selected.
Journal ArticleDOI
Elucidation of the Anticancer Potential of Selected Citrus Flavonoids Against NEDD4-1 in Breast Cancer
TL;DR: In silico and in vitro approaches have demonstrated hesperidin as the best NEDD4-1 inhibitory flavonoid as well as the associated mechanism behind the inhibitory potential of the screened selected compounds.
References
More filters
Journal ArticleDOI
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Yigong Shi,Joan Massagué +1 more
TL;DR: Current understanding on the mechanisms of TGF-β signaling from cell membrane to the nucleus is presented and the transcriptional regulation of target gene expression is reviewed.
Journal ArticleDOI
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
Chunaram Choudhary,Chanchal Kumar,Florian Gnad,Michael L. Nielsen,Michael Rehman,Tobias C. Walther,Jesper V. Olsen,Matthias Mann +7 more
TL;DR: A proteomic-scale analysis of protein acetylation suggests that it is an important biological regulatory mechanism and the regulatory scope of lysine acetylations is broad and comparable with that of other major posttranslational modifications.
Journal ArticleDOI
Colorectal cancer statistics, 2020.
Rebecca L. Siegel,Kimberly D. Miller,Ann Goding Sauer,Stacey A. Fedewa,Lynn F. Butterly,Lynn F. Butterly,Joseph C. Anderson,Joseph C. Anderson,Andrea Cercek,Robert A. Smith,Ahmedin Jemal +10 more
TL;DR: Progress against CRC can be accelerated by increasing access to guideline‐recommended screening and high‐quality treatment, particularly among Alaska Natives, and elucidating causes for rising incidence in young and middle‐aged adults.
Journal ArticleDOI
The biology and management of non-small cell lung cancer
TL;DR: Continued research into new drugs and combination therapies is required to expand the clinical benefit to a broader patient population and to improve outcomes in NSCLC.
Journal ArticleDOI
RING Domain E3 Ubiquitin Ligases
TL;DR: RING E3s have been linked to the control of many cellular processes and to multiple human diseases, and knowledge of the physiological partners, biological functions, substrates, and mechanism of action for most RING E 3s remains at a rudimentary stage.